(Q36300812)

13 August 2017

1 reference

title

Clinical pharmacogenetics of irinotecan (CPT-11). (English)

1 reference

13 August 2017

1 reference

Yuichi Ando

1

1 reference

PubMed ID

16257834

13 August 2017

Yoshinori Hasegawa

series ordinal

2

1 reference

PubMed ID

16257834

13 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

13 August 2017

Drug Metabolism Reviews

1 reference

13 August 2017

37

1 reference

13 August 2017

565-574

1 reference

13 August 2017

3

1 reference

Irinotecan in small-cell lung cancer.

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Rapid detection of UGT1A1 gene polymorphisms by newly developed Invader assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Effects of St. John's wort on irinotecan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Phase I Study and Pharmacokinetics of CPT-11 With 5-Day Continuous Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03602530500316254

10.1080/03602530500316254

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16257834